This startup offers a clinical genome interpretation platform that uses AI algorithms to analyze genomic data from various sources. The platform delivers actionable genomic insights to medical professionals, enabling faster and more accurate diagnostic reports.
Funding
Funding not disclosed
Founders
Product
Problem
The increasing volume of genomic data from next-generation sequencing (NGS) presents a significant bottleneck for clinical labs and hospitals. Manual interpretation of this data is time-consuming, costly, and can lead to delays in diagnosis and treatment.
Solution
Fabric Genomics offers a clinical genome interpretation platform that leverages AI to automate and streamline the analysis of NGS data, including whole genomes, exomes, and targeted panels. The platform prioritizes variants based on phenotype and genotype data, enabling faster and more accurate identification of disease-causing variants. Fabric Genomics' platform generates physician-ready clinical reports, facilitating rapid diagnosis, early intervention, and improved patient outcomes. The platform supports various applications, including rare disease diagnosis, hereditary risk screening, rapid NICU testing, and oncology panel analysis.
Target Audience
The primary target audience includes clinical labs, hospital systems, and academic centers that perform NGS testing for rare diseases, hereditary risk, and cancer.
Features
- AI-driven variant prioritization using algorithms like VAAST and Phevor
- Automated ACMG classification for consistent and accurate variant interpretation
- Comprehensive knowledge base with up-to-date annotations and reference data
- Customizable SOP-based workflows for efficient throughput
- Scalable cloud-based platform with secure API integration with LIMS and EMR systems
- Support for various NGS tests, including WGS, WES, and targeted panels
- Rapid turnaround time, with clinical reports ready in minutes for certain applications
- Clinical services for panel curation, SOP design, interpretation, and sign-out